Becton, Dickinson and Company (BDX) recently declared a quarterly dividend of 33 cents per share, which is payable on March 31 to shareholders of record on March 10. The company offers an industry-leading yield of 2%.

Company Description

Becton, Dickinson and Company is a medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines.

Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

A Recent Dividend

In early February, the company declared a quarterly dividend of 33 cents per share, which is payable on March 31 to shareholders of record on March 10. The company offers an industry-leading yield of 2%.

Strong Fiscal First Quarter

In Late January, Becton, Dickinson and Company released results for its fiscal first quarter. Revenues jumped 1.6% on a year-over-year basis. Earnings per share of $1.26 came in ahead of last year’s $1.07 and topped the consensus estimate by 9%.

“BD is off to a solid start to fiscal 2009. In particular, we continue to see strength in our Biosciences and Diagnostics segments and strong sales of insulin delivery products,” said Edward J. Ludwig, Chairman and Chief Executive Officer. “In addition, our strong earnings per share growth has given us the confidence to raise guidance for fiscal 2009.”

The company expects 9% to 11% earnings per share growth for the full fiscal year of 2009, versus t he prior year. Wall Street sees 10% growth.

More Solid Fundamentals

Becton, Dickinson and Company’s return on equity of 24% doubles the industry’s average of 12%. The company’s net profit margin of 16% is well above the industry average of 7%.

Content Courtesy: Zacks Investment Research

#1 Ranked Stocks Highlight Archive
To truly take advantage of the Zacks Rank, you need to first understand how it works. That is why we created the free special report: Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions.

1. (CPSI) Computer Programs & Systems – dividend yield of 5.7%, which is high above the industry averageComputer Programs & Systems, Inc. (CPSI) recently posted fourth-quarter results. Total revenues came in at...
2. (SHEN) Shenandoah Telecommunications – dividend yield of 1.2% is ahead of the industry averageShenandoah Telecommunications Co. (SHEN) has, for the most part, traded in line with the broader...
3. (TECH) Techne Corp – company’s return on equity (ROE) of 23% is high above the industry averageTechne Corp. (TECH), a Zacks #1 Rank (“strong buy”), recently declared a quarterly dividend of...
4. (BDX) Becton, Dickinson and Company – return on equity (ROE) of 23%, exceeding the industry average of 17%Becton, Dickinson and Company (BDX) offers a return on equity of 23%, exceeding the industry...
5. (SNA) – Snap-on, Inc – dividend yield of 2.1% remains very competitive when measured against the industry average of 0.9%Snap-on, Inc. (SNA) saw a sizeable share price boost on a strong second quarter, sending...
6. (ABT) – Abbott Laboratories – dividend yield of 2.5% – most companies within its industry group offer no dividendAbbott Laboratories (ABT) recently released stellar results for the second quarter and hiked its full-year...

Search Posts by Tag: BDX | Becton Dickinson And Company | Healthcare | Medical Instruments & Supplies

RSS Feeds by Tag: BDX | Becton Dickinson And Company | Healthcare | Medical Instruments & Supplies |

Other Posts by: vitalstocks | RSS Feed for this author